Category Archives: Cancer Research

Mikhail Blagosklonny

*A Closer Look at Mikhail Blagosklonny:

Mikhail Blagosklonny is a well known Scientist that has devoted his career to the study of Cancer as well as the aging process. Prior to devoting his career to Cancer and aging studies, Mikhail Blagosklonny was the Professor of the Oncology department at Roswell Park Cancer Institute. Although Blagosklonny enjoyed his status at Roswell Park Cancer Institute he had ambitions to advance his research studies.Mikhail Blagosklonny conducted his own research studies and found the drug “Rapamycin” not only treated Cancer but it also significantly slowed down the natural aging process. Blagosklonny is considered one of the strongest advocates for the use of “Rapamycin” in clinical research studies. The drug “Rapamycin” may one day be considered a miracle type drug.

*Education Credentials/ Other Related Experience:

Mikhail Blagosklonny has some impressive education credentials. He earned his MD in Internal Medicine from the First Pavlov State University of St. Petersburg. In addition Mikhail Blagosklonny has a PHD in Experimental Medicine from First Pavlov.In early 2000, Blagosklonny served as Associate Professor of Medicine at New York Medical College. He held this position for two years until before accept a position as Senior Scientist/ Researcher at Ordway Research Institute. He held this position for almost a decade before going Roswell Park Cancer Institute.A good deal of Mikhail Blagosklonny’s time is used studying “Cell Stress Biology” as well as its applications. In addition, Mikhail Blagosklonny focuses heavily upon the role that immunity plays in longevity and increased lifespan. One thing is for sure he is certainly a valuable asset to Roswell Park Cancer Institute.Blagosklonny has written several medical journals and editorials for publication. The topics covered included “Cell Death & Differentiation” as well as “Aging” and “Cell Cycle”. His medical publications received great attention as well as public interest within the medical community. It may be possible in the future to abolish aging altogether.

*Impact on Medical Science/ Publications:

Mikhail Blagosklonny has had a strong personal impact not only on medical science but on society as a whole. Many now wonder is it possible to reverse the aging process indefinitely? A great deal more research is certainly needed in the area of aging, cell regeneration and Cancer.On occasion, Mikhail Blagosklonny does lecture on his current research findings. One topic of great interest is ” Pathology beyond Oncology“. In addition, “Genetics & Cancer is another area of great interest. Blagosklonny plans to dive deeper into researching Specific Gene Mutations and Cancer development.

Oncotarget: The Center for Accessible and Reliable Medical Research

Oncotarget is a medical journal that focuses on research in the field of oncology. The journal is published every week by Impact Journals. It is licensed under Creative Commons Attribution as an open access journal and is highly rated by the Journal Citation Reports. Recently, the journal started publishing papers on other topics like Neuroscience, Cardiology, Cell Biology, Pharmacology, Metabolism, and Endocrinology.

The Editorial Team

Oncotarget boasts an experienced editorial team that comprises of the editors-in-chief Andrei V. Gudkov and Mikhail V. Blagosklonny, both from the Roswell Park Cancer Institute. Other members of the editorial board include Fredrick Alt & Arthur B. Pardee from Harvard Medical School, Carlo M. Croce from Ohio State University, Ronald A. DePinho from The University of Texas, and Alexander Varshavsky from California Institute of Technology.

Under the leadership of the experienced editorial team, Oncotarget aims at eliminating human diseases. With its free-access, the Journal breaks the barrier between medical specialties and makes scientific research widely and readily available.

Social Media Presence

In the recent past, organizations have started using the social media platforms to reach out to a wider audience. Oncotarget has not been left behind in these new developments, having opened Twitter, Facebook, YouTube, and Google Plus accounts. Their twitter handle is @OncotargetJrnl, their Facebook profile name is Oncotarget, and their YouTube channel is Oncotarget Journals. In all these social media platforms, they post content covered in their journals, both in writing and in videos. Oncotarget is published by Impact Journals

About Andrei Gudkov

Prof. Andrei V. Gudkov is a co-chief-editor of Oncotarget. Being a professor at Roswell Park Cancer Institute, Andrei serves as the senior VP for Basic Research in the institution, with an emphasis on gene & drug discovery for cancer treatment. He studied experimental oncology at National Cancer Center, USSR and Molecular Biology from Moscow State University, USSR. Andrei is a co-founder of Cleveland BioLabs, Inc.

About Mikhail Blagosklonny

Prof. Mikhail V. Blagosklonny is a co-chief-editor of Oncotarget. He is a professor at New York’s Roswell Park Cancer Institute. He is interested in researches on molecular biology, clinical investigation, and cellular biology. Mikhail boasts more than 250 articles to his name as well as being an Associate Editor for several publications. He was the Editor-in-Chief of Cell Cycle.

Follow Oncotarget journal on Twitter.